Efficacy maintained despite reduced chemo in multiple myeloma

blood cells.jpg

Intensity reduction of induction therapy for older, newly diagnosed multiple myeloma patients does not compromise the efficacy of treatment; it does, however, substantially reduce toxicity, according to newly published research.

Read more about this at the coverage provided at CancerTreatment.net.

LymphomaInfo Social